メディカル/サイエンス・アドバイザー

Shun’ichiro Taniguchi, Ph.D.

Dr. Taniguchi is a co-founder of the company and served as Director of the Board. He is a Professor of Institute of Biomedical Sciences, and a professor of Shinshu University Graduate School of Medicine. Prior to Shinshu University he was an Associate Professor of Medical Institute of Bioregulation, Kyushu University. He completed research fellowship training at the National Cancer Institute, NIH in Bethesda. He received a B.S. in Physics and Ph.D. in both Biology and Medicine from Kyushu University.

Minoru Fujimori, M.D., Ph.D.

Dr. Fujimori is a Professor of Breast Surgery of Tokyo Medical University Ibaraki Medical Center. Prior to this, he was Surgeon-in-Chief, and Associate Professor of Breast and Endocrine Surgery at Shinshu University School of Medicine. Dr. Fujimori completed research fellowship training at University of Washington School of Medicine after having received his education and training in medicine at Shinshu University Hospital, Japanese Foundation of Cancer Institute, and some other institutes. He received a Ph.D. from Shinshu University School of Medicine.

Edward A. Sausville, M.D., Ph.D.

Associate Director for Clinical Research of the University of Maryland Greenebaum Cancer Center. He is also Professor of Medicine, Adjunct Professor of Pharmacology and Experimental Therapeutics in the University of Maryland School of Medicine, and Affiliate Professor of Pharmaceutical Science in the University of Maryland School of Pharmacy. He received his Ph.D. in Pharmacology in 1978 and M.D. in 1979 from the Albert Einstein College of Medicine of Yeshiva University in New York City. Following medical house-staff training at the Brigham and Women’s Hospital in Boston, where he was a Fellow in Medicine at Harvard Medical School, he was a Medical Staff Fellow at the National Cancer Institute (NCI), National Institutes of Health in Bethesda, MD and is certified in Internal Medicine and Medical Oncology. His research interests include elucidation of the molecular mechanism of novel therapeutic agents, signal transduction modulators for cancer treatment, and early phase clinical trials of new drugs for cancer treatment.

Mario Sznol, M.D.

Professor of Internal Medicine and Co-Director of the Melanoma Program of the Yale Cancer Center. Prior to Yale, he was Vice President of Clinical Affairs for Vion Pharmaceuticals. Prior to Vion, Dr. Sznol was Head of the Biologics Evaluation Section, Investigational Drug Branch, Cancer Therapy Evaluation Program of the National Cancer Institute. During his professional career, Dr. Sznol has focused on clinical development of cytokines, vaccines, antibodies and bacterial products for treatment of cancer. Dr. Sznol conducted his fellowship in Medical Oncology at Mt. Sinai School of Medicine, and his residency in Internal Medicine at Baylor College of Medicine in Houston.